Information  X 
Enter a valid email address

SolGold PLC (SOLG)

  Print      Mail a friend       Annual reports

Wednesday 15 May, 2019

SolGold PLC

Quarterly MD&A Filed in Canada

RNS Number : 0175Z
SolGold PLC
15 May 2019
 

15 May 2019

 

SolGold plc

("SolGold" or the "Company")

 

Quarterly MD&A Filed in Canada

 

 

The Board of SolGold (LSE and TSX code: SOLG) is pleased to advise all shareholders and interested investors that the Company's website contains access to a copy of the Quarterly Financial and Management Discussion and Analysis ("MD&A") required to be filed on Sedar in Canada, in connection with the Company's quarterly financial period ended 31 March 2019.  This additional information is available in the Financial Reports section of the Investor Centre on the Company's website: www.solgold.com.au

 

By order of the Board

Karl Schlobohm

Company Secretary

 

References to figures and tables relate to the version visible in PDF format by clicking the link below:

http://www.rns-pdf.londonstockexchange.com/rns/0175Z_1-2019-5-14.pdf

 

CONTACTS

 

Nicholas Mather

SolGold Plc (Chief Executive Officer) [email protected]

 

Tel: +61 (0) 7 3303 0665

+61 (0) 417 880 448

Karl Schlobohm

SolGold Plc (Company Secretary) [email protected]

 

Tel: +61 (0) 7 3303 0661

Anna Legge

SolGold Plc (Corporate Communications) [email protected]

 

Tel: +44 (0) 20 3823 2131

Gordon Poole / Nick Hennis Camarco (Financial PR / IR) [email protected]

 

Tel: +44 (0) 20 3757 4997

Andrew Chubb / Ingo Hofmaier

Hannam & Partners (Joint Broker and Financial Advisor)

[email protected]

 

Tel: +44 (0) 20 7907 8500

Ross Allister / David McKeown

Peel Hunt (Joint Broker and Financial Advisor)

[email protected]

 

Tel: +44 (0)20 7418 8900

James Kofman / Darren Wallace

Cormark Securities Inc. (Financial Advisor)

[email protected]

 

Tel: +1 416 943 6411

 

Follow us on twitter @SolGold_plc


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCUSRVRKVAVAAR

a d v e r t i s e m e n t